These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4671348)
21. Clinical experience of the treatment of drug-resistant pulmonary tuberculosis with rifampicin combined with ethambutol and capreomycin. Wäre M; Heinivaara O; Elo R; Tala E Scand J Respir Dis Suppl; 1969; 69():59-63. PubMed ID: 4906375 [No Abstract] [Full Text] [Related]
23. Treatment of tuberculosis in patients with pre-existing liver disease or following hepatotoxic drug reactions. Robson SC; Pillans P; Willcox PA S Afr Med J; 1993 Jun; 83(6):432-4. PubMed ID: 8211464 [No Abstract] [Full Text] [Related]
24. A trial of intermittent rifampicin and ethambutol in retreatment regimens. Zierski M Scand J Respir Dis Suppl; 1973; 84():132-5. PubMed ID: 4522067 [No Abstract] [Full Text] [Related]
26. [Complications with rifampicin treatment: one case with anuria (author's transl)]. Chevalier JP; Plantier J; Kofman J; Montagnon B; Magnin F; Perrin-Fayolle M; Traeger J Poumon Coeur; 1980; 36(4):287-91. PubMed ID: 7443620 [TBL] [Abstract][Full Text] [Related]
27. [Rifomycin in the treatment of pulmonary tuberculosis: preliminary note]. Tacquet A; Savinel E; Devulder B; Duthoit A Acta Tuberc Pneumol Belg; 1969; 60(3):529-44. PubMed ID: 5371678 [No Abstract] [Full Text] [Related]
28. [Hepatic coma caused by a rifampicin overdosage]. Taranger J; Girbal JP; Terrasson de Fougeres G; Alibert R Mars Med; 1970; 107(11):923-5. PubMed ID: 5488515 [No Abstract] [Full Text] [Related]
29. [Side effects of rifampicin used intermittently in treatment of chronic pulmonary tuberculosis]. Zierski M; Kucharska A; Wislawska-Orlowska B Gruzlica; 1973 Nov; 41(11):1139-45. PubMed ID: 4765794 [No Abstract] [Full Text] [Related]
30. Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment. Tousek J Respiration; 1971; 28():Suppl:116-22. PubMed ID: 5150791 [No Abstract] [Full Text] [Related]
31. Hepatorenal failure with self-initiated intermittent rifampicin therapy. Rothwell DL; Richmond DE Br Med J; 1974 Jun; 2(5917):481-2. PubMed ID: 4834100 [No Abstract] [Full Text] [Related]
32. [Histopathological and histochemical study of the liver during antituberculotic polychemotherapy in children ]. Mihailovici MS Morphol Embryol (Bucur); 1987; 33(3):205-8. PubMed ID: 2958698 [No Abstract] [Full Text] [Related]
33. [Adverse reactions to rifampicin treatment of tuberculosis and nonspecific lung diseases]. Madeĭ B; Malak S; Shelezhinskiĭ K Probl Tuberk; 1980 Nov; (11):27-9. PubMed ID: 7454718 [No Abstract] [Full Text] [Related]
34. [Report on 13 cases (including 3 deaths) of liver damage induced by rifampicin (author's transl)]. Tong YY Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Mar; 3(1):35-8. PubMed ID: 7428575 [No Abstract] [Full Text] [Related]
36. [Interference of rifampicin on liver cytology]. Bertelli A; Tongiani R; Chieli E; Malvaldi G Med Chir Dig; 1976 May; 5(6):345-8. PubMed ID: 1011896 [No Abstract] [Full Text] [Related]
37. [Jaundice and rifampicin]. Piéron R; Marien C; Jagueux M Sem Hop; 1971 Apr; 47(20):1286-95. PubMed ID: 4326532 [No Abstract] [Full Text] [Related]
38. [Study on the incidence of Australia antigen in a controlled experiment of treatment with rifampicin]. Patricolo MR Arch Monaldi; 1974; 29(5-6):477-82. PubMed ID: 4467825 [No Abstract] [Full Text] [Related]
39. [Hepatic tolerance in man of rifampicin-isoniazid association]. Toulet J; Plomteux G; Viteau JM; Abiven M; Bonfante N J Med Liban; 1971; 24(6):651-8. PubMed ID: 5146848 [No Abstract] [Full Text] [Related]
40. [Study of hepatic function in patients treated with rifampicin]. Morère P; Bourreille J; Matray F; Stain JP; Métayer P Rev Tuberc Pneumol (Paris); 1970; 34(3):403-14. PubMed ID: 5510435 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]